Back

An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer

Co, I. L.; Yu, C.; Lamorte, S.; Ciudad, M. T.; Landon-Brace, N.; Cadavid, J. L.; Xia, Z.; Fomina, A.; Nurse, M.; McGaha, T. L.; Campbell, K. R.; McGuigan, A. P.

2023-07-14 bioengineering
10.1101/2023.07.13.548899 bioRxiv
Show abstract

In pancreatic ductal adenocarcinoma (PDAC), tumour associated macrophages (TAMs) are a heterogeneous immune cell population that interact with cancer cells to promote malignancy, chemo-resistance, and immunosuppression. Aside from TAMs, hypoxia is a prominent feature of PDAC that can rewire cells to survive and enhance malignancy in the tumour microenvironment (TME). Deciphering the interactions between macrophages, cancer cells and hypoxia could lead to the development of effective immune-targeted therapies for PDAC. However, there are only a few models that physiologically recapitulate the PDAC TME and allow for meaningful interrogation of cancer-immune cell interactions in hypoxia. Here, we develop a model of primary macrophages and PDAC patient organoid-derived cells by adapting TRACER, a paper-based, engineered 3D model that allows snapshot analysis of cellular response in hypoxia. In this study, we establish a direct co-culture method of primary macrophages and PDAC organoid cells in TRACER and demonstrate that TRACER co-cultures generate hypoxic gradients and show expected phenotypic responses to this hypoxic gradient. Moreover, we report for the first time in a human in vitro model that hypoxic macrophages exert a graded chemoprotective effect on gemcitabine-treated PDAC organoid cells, and that interactions between cancer cells and macrophages from the inner layers of TRACER indirectly attenuate the inflammatory response of donor-derived T-cells. Overall, the TRACER co-culture system is a novel, fully human 3D in vitro cancer-immune model for evaluating the response of macrophages and cancer cells in a hypoxic gradient.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Advanced Science
249 papers in training set
Top 2%
8.4%
2
APL Bioengineering
18 papers in training set
Top 0.1%
8.4%
3
Scientific Reports
3102 papers in training set
Top 12%
7.2%
4
Cancer Research
116 papers in training set
Top 0.4%
4.9%
5
Theranostics
33 papers in training set
Top 0.2%
3.6%
6
iScience
1063 papers in training set
Top 5%
3.6%
7
Advanced Healthcare Materials
71 papers in training set
Top 0.6%
3.6%
8
Journal of The Royal Society Interface
189 papers in training set
Top 1%
3.6%
9
Lab on a Chip
88 papers in training set
Top 0.4%
2.9%
10
Disease Models & Mechanisms
119 papers in training set
Top 0.6%
2.7%
11
Bioengineering & Translational Medicine
21 papers in training set
Top 0.3%
1.9%
50% of probability mass above
12
Biofabrication
32 papers in training set
Top 0.5%
1.7%
13
Nature Communications
4913 papers in training set
Top 52%
1.7%
14
Communications Biology
886 papers in training set
Top 11%
1.5%
15
Cell Systems
167 papers in training set
Top 8%
1.5%
16
Advanced Functional Materials
41 papers in training set
Top 1%
1.3%
17
Cell Reports
1338 papers in training set
Top 27%
1.3%
18
Acta Biomaterialia
85 papers in training set
Top 0.6%
1.2%
19
Science Advances
1098 papers in training set
Top 23%
1.2%
20
Frontiers in Immunology
586 papers in training set
Top 5%
1.2%
21
eLife
5422 papers in training set
Top 49%
1.2%
22
Computers in Biology and Medicine
120 papers in training set
Top 3%
1.1%
23
Nature Biomedical Engineering
42 papers in training set
Top 1%
1.1%
24
Biomaterials
78 papers in training set
Top 0.9%
1.0%
25
PLOS ONE
4510 papers in training set
Top 64%
0.9%
26
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 2%
0.9%
27
Cancer Immunology, Immunotherapy
11 papers in training set
Top 0.3%
0.9%
28
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.9%
0.9%
29
Stem Cell Research & Therapy
30 papers in training set
Top 0.7%
0.8%
30
Biomedicines
66 papers in training set
Top 3%
0.8%